Drug
AZD 8931 clinical trials
Also written AZD8931.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
10 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 3
AstraZeneca (7) · UNICANCER (2) · University College, London (1)
Often tested with
Tested in the same studies.
Vistusertib (2) · AZD4547 (2) · Capivasertib (2) · AZD 6244 (2) · Vandetanib (2) · Olaparib (2) · Durvalumab (2) · Bicalutamide (1)
Studies
Open first, then newest update. How each study uses AZD 8931 is read from its arms, and is right about nine times in ten.
Testing it · 10
- SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast CancerActive, not recruitingPhase 2UNICANCERNCT02299999Written as AZD8931
- SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC PatientsCompletedPhase 2UNICANCERNCT02117167Written as AZD8931
- Phase I/II Trial of Antagonism of HER in GI CancerCompletedPhase 2University College, LondonNCT01862003Written as AZD8931
- Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)CompletedPhase 1/2AstraZenecaNCT00900627Written as AZD8931
- Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric CancerTerminatedPhase 2AstraZenecaNCT01579578Written as AZD8931
- Healthy Volunteers, Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] AZD8931CompletedPhase 1AstraZenecaNCT01284595Written as [14C] AZD8931
- Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast CancerTerminatedPhase 2AstraZenecaNCT01151215Written as AZD8931
- Study of AZD8931 in Patients With Advanced Solid MalignanciesCompletedPhase 1AstraZenecaNCT00637039Written as AZD8931
- A Study to Compare Two Different Tablet Formulations of AZD8931 in Healthy Males and FemalesCompletedPhase 1AstraZenecaNCT01330758Written as AZD8931
- A Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 TabletsCompletedPhase 1AstraZenecaNCT00879346Written as AZD8931